Literature DB >> 30195991

New Perspectives on the Pathogenesis of PCOS: Neuroendocrine Origins.

Kirsty A Walters1, Robert B Gilchrist2, William L Ledger2, Helena J Teede3, David J Handelsman4, Rebecca E Campbell5.   

Abstract

Polycystic ovary syndrome (PCOS) is the most common endocrine condition in reproductive-aged women. It is characterized by reproductive, endocrine, metabolic, and psychological features. The cause of PCOS is unknown, thus there is no cure and its management remains suboptimal because it relies on the ad hoc empirical management of symptoms only. We review here the strong support for PCOS having a neuroendocrine origin. In particular, we focus on the role of aberrant hypothalamic-pituitary function and associated hyperandrogenism, and their role as major drivers of the mechanisms underpinning the development of PCOS. This important information now provides a target site and a potential mechanism for the future development of novel, targeted, and mechanism-based effective therapies for the treatment of PCOS.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  androgen receptor; brain; hyperandrogenism; polycystic ovary syndrome

Mesh:

Year:  2018        PMID: 30195991     DOI: 10.1016/j.tem.2018.08.005

Source DB:  PubMed          Journal:  Trends Endocrinol Metab        ISSN: 1043-2760            Impact factor:   12.015


  22 in total

Review 1.  Hyperandrogenic origins of polycystic ovary syndrome - implications for pathophysiology and therapy.

Authors:  David H Abbott; Daniel A Dumesic; Jon E Levine
Journal:  Expert Rev Endocrinol Metab       Date:  2019-02-15

Review 2.  Insulin resistance and PCOS: chicken or egg?

Authors:  P Moghetti; F Tosi
Journal:  J Endocrinol Invest       Date:  2020-07-09       Impact factor: 4.256

Review 3.  Emerging Roles of Anti-Müllerian Hormone in Hypothalamic-Pituitary Function.

Authors:  Anne-Laure Barbotin; Maëliss Peigné; Samuel Andrew Malone; Paolo Giacobini
Journal:  Neuroendocrinology       Date:  2019-07-05       Impact factor: 4.914

Review 4.  Animal Models to Understand the Etiology and Pathophysiology of Polycystic Ovary Syndrome.

Authors:  Elisabet Stener-Victorin; Vasantha Padmanabhan; Kirsty A Walters; Rebecca E Campbell; Anna Benrick; Paolo Giacobini; Daniel A Dumesic; David H Abbott
Journal:  Endocr Rev       Date:  2020-07-01       Impact factor: 19.871

5.  Bio-enhancement of Soy Isoflavones (Genistein & Daidzein) Using Bacillus coagulans in Letrozole Induced Polycystic Ovarian Syndrome by Regulating Endocrine Hormones in Rats.

Authors:  Jeshica Bulsara; Arun Soni; Pragati Patil; Kripa Halpati; Sonal Desai; Sanjeev Acharya
Journal:  Probiotics Antimicrob Proteins       Date:  2022-04-11       Impact factor: 4.609

6.  Efficacy of Bariatric Surgery in the Treatment of Women With Obesity and Polycystic Ovary Syndrome.

Authors:  Lili Hu; Li Ma; Xinyi Xia; Tao Ying; Minzhi Zhou; Shuhua Zou; Haoyong Yu; Jun Yin
Journal:  J Clin Endocrinol Metab       Date:  2022-07-14       Impact factor: 6.134

Review 7.  Curtailing PCOS.

Authors:  Selma Feldman Witchel; Helena J Teede; Alexia S Peña
Journal:  Pediatr Res       Date:  2019-10-18       Impact factor: 3.756

Review 8.  Endometriosis and polycystic ovary syndrome are diametric disorders.

Authors:  Natalie L Dinsdale; Bernard J Crespi
Journal:  Evol Appl       Date:  2021-05-14       Impact factor: 4.929

9.  Constitutive expression of Steroidogenic factor-1 (NR5A1) disrupts ovarian functions, fertility, and metabolic homeostasis in female mice.

Authors:  Emmi Rotgers; Barbara Nicol; Karina Rodriguez; Saniya Rattan; Jodi A Flaws; Humphrey Hung-Chang Yao
Journal:  FASEB J       Date:  2021-08       Impact factor: 5.834

10.  The relationships of sex hormone-binding globulin, total testosterone, androstenedione and free testosterone with metabolic and reproductive features of polycystic ovary syndrome.

Authors:  Pomme I H G Simons; Olivier Valkenburg; Judith A P Bons; Coen D A Stehouwer; Martijn C G J Brouwers
Journal:  Endocrinol Diabetes Metab       Date:  2021-05-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.